New efficacy against liver cancer discovered in Artemisinin
A recent study by HOU Junmei, a doctoral student with the research group of Prof. WANG Hui with the CAS Institute of Nutritional Sciences, shows that Artemisinin and its derivate Dhydroartemisinin are promising therapeutic agents against liver cancer, either used alone or in combination with the conventional chemotherapy. Earlier, Wang Tao, another member of Wang's group, had discovered their functions against ovarian cancer.
As reported in a recent issue of Clinical Cancer Research, the researchers also revealed the underlying mechanisms of Artemisinin and its derivate Dhydroartemisinin's action in human hepatoma cells.
The researchers suggested that Artemisinin and its derivate Dihydroartemisinin have significant anticancer effects against human hepatoma cells, with minimal effects on normal cells, indicating that they are promising therapeutics for human hepatoma used alone or in combination with other therapies.
